Stress exposure triggers ligand-independent EGF receptor (EGFR) endocytosis, but its postendocytic fate and role in regulating signalling are unclear. We show that the p38 MAP kinase-dependent, EGFR tyrosine kinase (TK)-independent EGFR internalization induced by ultraviolet light C (UVC) or the cancer therapeutic cisplatin, is followed by diversion from the canonical endocytic pathway. Instead of lysosomal degradation or plasma membrane recycling, EGFR accumulates in a subset of LBPA-rich perinuclear multivesicular bodies (MVBs) distinct from those carrying EGF-stimulated EGFR. Stress-internalized EGFR co-segregates with exogenously expressed pre-melanosomal markers OA1 and fibrillar PMEL, following early endosomal sorting by the actin polymerization-promoting WASH complex. Stress-internalized EGFR is retained intracellularly by continued p38 activity in a mechanism involving ubiquitin-independent, ESCRT/ALIX-dependent incorporation onto intraluminal vesicles (ILVs) of MVBs. In contrast to the internalization-independent EGF-stimulated activation, UVC/cisplatin-triggered EGFR activation depends on EGFR internalization and intracellular retention. EGFR signalling from this MVB subpopulation delays apoptosis and might contribute to chemoresistance.
T he epidermal growth factor receptor (EGFR) is an archetypal receptor tyrosine kinase (TK) typically activated by ligand binding to its extracellular domain. In the canonical pathway, EGFR phosphorylates downstream targets following activation, initiating signalling cascades that drive various cellular responses, including cell proliferation and inhibition of apoptosis 1 . EGFR is subsequently internalized, and its endocytic trafficking is a major regulatory mechanism for receptor activity, as ligand-induced EGFR lysosomal degradation leads to signal termination 2 . However, the established view that EGFR trafficking functions only for signal termination has been challenged in a number of reports demonstrating that EGFR can continue to signal along the endocytic pathway 3 .
In cancer, EGFR signalling is often deregulated, contributing to tumorigenesis, therapy resistance and poor patient survival 4 . Despite the demonstrated benefits of EGFR-targeting agents, patient responses remain inconsistent and clinical trials in combination with chemotherapy have been disappointing 5 . Although exposure to chemotherapy and other stresses has been shown to elicit ligand-independent EGFR internalization 6, 7 , the nature of the endocytic compartment(s) through which stressinternalized EGFR traffics, the molecular mechanisms underlying this trafficking and their effects on downstream signalling remain unknown 8 . Here we analyse the post-endocytic fate of the EGFR following exposure to ultraviolet light C (UVC) and the chemotherapeutic drug, cisplatin, and show that EGFR undergoes p38-dependent accumulation in a subpopulation of perinuclear multivesicular bodies (MVBs) that are distinct from those that traffic ligand-stimulated EGFR to the lysosome but contain exogenously expressed markers of melanosome biogenesis. Segregation of stress-induced and ligand-stimulated EGFR into different populations of MVBs depends on the WASP and Scar homologue (WASH) complex that regulates actin dynamics. Unlike ligand-stimulated EGFR, which is activated on the plasma membrane, internalization of stress-induced EGFR is a requirement for its activation. Intracellular retention of stressinduced EGFR in MVBs is independent of EGFR ubiquitination but depends on the endosomal sorting complex required for transport (ESCRT) machinery and ALG-2-interacting Protein X (ALIX) and is required for stress-induced EGFR signalling and protection from apoptosis.
Results

Roles of p38 in stress-induced EGFR perinuclear accumulation.
Immunofluorescence staining of HeLa cells showed that both UVC and cisplatin elicit a striking perinuclear accumulation of internalized EGFR (Fig. 1a and Supplementary Fig. 1a ), but western blotting cell lysates showed that, unlike EGF stimulation, they do not induce detectable EGFR degradation ( Supplementary Fig. 1b ). Quantitative analysis of EGFR surface downregulation showed that the perinuclear intracellular pool of EGFR is maintained for 42 h and accounts for B50% of total EGFR (Fig. 1a ). In keeping with previous studies, UVC-elicited p38 activity was required to promote initial EGFR internalization ( Supplementary Fig. 1c ). Interestingly, p38 inhibition after UVC-induced perinuclear EGFR accumulation resulted in redistribution of perinuclear EGFR to the plasma membrane (Fig. 1b) , revealing a novel role for p38 in EGFR retention in the perinuclear compartment distinct from its role in EGFR internalization. This is in marked contrast to the p38-independent post-endocytic fate of ligand-stimulated EGFR, which was degraded. Treatment with the clathrin inhibitor PITSTOPII blocked UVC-induced EGFR internalization but when PITSTOPII was added after UVC-induced EGFR perinuclear accumulation to prevent re-internalization of any recycled receptor, the EGFR was retained intracellularly (Fig. 1c) . This indicates that UVC-exposed EGFR does not undergo continuous internalization and recycling.
However, if p38 is inhibited after UVC-induced EGFR perinuclear accumulation, EGFR recycles to the plasma membrane in a manner that siRNA-mediated depletion shows is dependent on Rab11 (Fig. 1d) . In contrast, endocytosis of Transferrin Receptor (TfR) did not require p38 activity, and TfR recycling was unaffected by UVC exposure, indicating EGFR-specific p38-dependent internalization and retention ( Supplementary Fig. 1c,d ).
Segregation of stress-exposed EGFR in an MVB subpopulation. UVC-exposed EGFR localized initially to EEA1-positive early endosomes, as previously reported 6, 9 , but this localization was progressively lost as the receptor accumulated perinuclearly with negligible co-localization with the lysosomal marker Lamp1 (Supplementary Fig. 2a ). The striking perinuclear distribution of UVC/cisplatin-stimulated EGFR, together with the availability of this receptor pool for recycling upon p38 inhibition, suggested that EGFR might be sequestered in recycling endosomes. However, stress-activated EGFR showed very limited co-staining with Rab11, although it passed through Rab11-positive recycling endosomes when recycling was induced by p38 inhibition ( Supplementary Fig. 2b ). To our surprise, high-resolution cryoimmuno electron microscopy (EM) localization of EGFR 1 h post UVC stress revealed that EGFR specifically accumulated in MVBs morphologically indistinguishable from those that traffic ligandstimulated EGFR ( Fig. 1e and Supplementary Fig. 1e ). Sequential stimulation first with UVC (which leaves B50% EGFR on the cell surface) and then with fluorescent EGF revealed the presence of separate populations of EGFR-containing MVBs in the same cell (Fig. 1f) . Similarly, incubating with anti-EGFR gold to track all populations of EGFR and subsequently stimulating first with UVC and then with EGF conjugated to horseradish peroxidase (HRP), allowed the identification of two populations of EGFR-positive MVBs, either containing or not containing EGF ( Supplementary  Fig. 1f ). The remarkable separation of ligand-and stressstimulated EGFR in distinct endosomal subpopulations was particularly clear in cells with enlarged endosomes following expression of constitutively active Rab5-Q79L (ref. 10); Fig. 1g) .
We have previously shown that ligand-stimulated EGFR is trafficked in a subset of MVBs 11 , but the composition and function of non-EGFR-containing MVBs remain poorly characterized. In this respect, melanosomes are lysosome-related organelles generated from a subset of MVBs diverted from the canonical degradative pathway in pigmented cells 12 . Within those MVBs, premelanosome protein (PMEL) undergoes proteolytic processing to generate fibrils (fibrillar PMEL) upon which melanin is deposited 13, 14 , whereas unprocessed non-fibrillar PMEL and cleaved C-terminal PMEL fragments containing its transmembrane domain traffic along the degradative pathway 15 . We recently showed that the pre-melanosomal G-protein-coupled receptor OA1, when exogenously expressed in HeLa cells, localizes to a subset of MVBs distinct from those carrying ligand-stimulated EGFR 16 . We now find, by immunofluorescence of HeLa cells transfected with markers of melanosome biogenesis, increased colocalization of EGFR with OA1 and fibrillar PMEL in UVCexposed, compared with EGF-treated, HeLa cells (Fig. 2a) . In contrast, unprocessed non-fibrillar PMEL showed increased colocalization with EGF-bound compared with UVC-exposed EGFR. Parallel cryo-immunoEM showed segregation of stressexposed EGFR within MVBs containing OA1 and fibrillar PMEL, whereas EGF-bound EGFR segregated within MVBs containing non-fbrillar PMEL and C-terminal PMEL fragments ( Fig. 2b and Supplementary Fig. 3a) .
Role of WASH in segregation of stress-exposed EGFR. The finding that OA1 and fibrillar PMEL co-segregate with cargoes to different destinations 18 , such as retromer-mediated endosome-to-Golgi retrieval 19 and plasma membrane recycling 20 . The WASH complex has also been shown to associate with BLOC-1 (biogenesis of lysosomal organelles complex-1), required for selective cargo exit from early endosomes to melanosomes 21 , suggesting that WASH-mediated actin polymerization may function in melanosome biogenesis 22 . We found that WASH is required for segregation of stress-internalized EGFR away from EGF-bound EGFR by comparing mouse embryonic fibroblasts (MEFs) derived from control flox/flox and Cre-mediated conditional WASH knockout (WASHOUT) embryos 23 . In flox/flox MEFs treated first with UVC and then fluorescent EGF, there are two populations (EGF positive and EGF negative) of EGFR present (Fig. 3a) . However, in WASHOUT MEFs, EGFR and EGF signals are totally merged in the same endosomal compartments. Furthermore, although in flox/flox MEFs (like in HeLa cells) UVC-exposed EGFR shows greater co-localization with OA1 and fibrillar PMEL than EGF-bound EGFR, in WASHOUT MEFs UVC-exposed and EGF-bound EGFR co-stain equally well with these markers (Fig. 3b , quantified in Fig. 3c ). Similarly, in flox/flox MEFs, EGF-bound EGFR shows greater co-localization with non-fibrillar PMEL than UVCexposed receptor, but this difference is lost in WASHOUT MEFs. The requirement for the WASH complex in segregation of stress-internalized EGFR along with pre-melanosomal factors away from ligand-stimulated EGFR contrasts with the unimpaired lysosomal degradation of EGF-bound EGFR and plasma membrane recycling of TfR in WASH knockouts 23 .
Role of ESCRTs/ALIX in MVB retention of stress-exposed EGFR.
Following WASH-dependent segregation, stress-stimulated EGFR accumulates in MVBs that do not fuse with lysosomes. To determine whether the failure to fuse with lysosomes was due to stressinduced lysosomal damage, EGFR degradation was measured in cells stimulated first with UVC and then with EGF. UVC-exposed cells clearly retained the capacity for degradation of EGFR ( Supplementary Fig. 3b ). Furthermore, UVC-exposed cells showed only a minor increase in lysosomal pH, as demonstrated by only marginal reductions in neutral red and lysotracker accumulation ( Supplementary Fig. 3c ). Taken together, these results indicate that if there is significant lysosomal damage following UVC exposure, this is rapidly recovered and cannot explain the accumulation of EGF in perinuclear MVBs for Z4 h ( Supplementary Fig. 3d ). The best characterized MVB sorting machinery is the ESCRT complex system 24 , which recognizes ubiquitinated cargoes such as ligand-stimulated EGFR and sorts them onto intraluminal vesicles (ILVs) of MVBs that subsequently fuse with lysosomes for degradation. We found that, in contrast to EGF stimulation, UVC or cisplatin exposure did not trigger EGFR ubiquitination (Fig. 4a) . Ultraviolet exposure may downregulate the cellular ubiquitination machinery 25 , but EGF-dependent EGFR ubiquitination was still present, although slightly reduced, in UVC-pre-treated cells, showing that the ubiquitination capacity was only marginally abridged ( Fig. 4b) . Consistent with the absence of a role for ubiquitination in stress-induced EGFR trafficking, ubiquitinationdeficient mutant EGFR-15KR 26 accumulated on both MVBlimiting membranes and ILVs following UVC exposure (Fig. 4c) , and recycled to the plasma membrane following p38 inhibition (Fig. 4d) , just as control EGFR-wt, when expressed in porcine aortic endothelial (PAE) cells. Moreover, EGFR-15KR cosegregated with transfected OA1 following both EGF and UVC exposure, whereas, as reported above in HeLa and flox/flox MEFs, EGFR-wt only co-localized with OA1 following UVC exposure (Fig. 4e) , suggesting receptor ubiquitination as critical for its retention on the degradative pathway.
PMEL, which co-segregates with stress-activated EGFR, also undergoes ubiquitin-independent sorting onto ILVs, but independently of ESCRTs and requiring the tetraspanin CD63 (ref. 15 ). However, surprisingly, and despite lack of EGFR ubiquitination, knockdown of the ESCRT-0 component, Hrs, or the ESCRT-I component Tsg101 (ref. 24 ) resulted in inhibition of ILV formation and a reduced density of UVC-exposed EGFR on MVBs, where it predominantly localized to the limiting membranes (Fig. 4f, quantified in Supplementary Fig. 4a and validated with alternative siRNA sequences in Supplementary  Fig. 4b ). Presumably, for stress-internalized EGFR, the ESCRT-0 complex enables membrane recruitment of ESCRT-I rather than ubiquitinated cargo recognition 24 . Recent reports have shown that binding to any ESCRT can mediate ubiquitin-independent cargo sorting 27 , and the existence of a ESCRT-dependent, ubiquitin-independent pathway of ILV cargo sorting that depends on the ESCRT adaptor ALIX 28, 29 . However, no role for ALIX has been demonstrated in sorting of EGF-stimulated EGFR onto ILVs or its targeting to lysosomes for degradation 30 . ALIX is recruited to MVBs by binding to the rare lipid lysobisphosphatidic acid (LBPA) 30 , which we previously showed to be absent from EGF-stimulated EGFR-containing MVBs 11 , but present in MVBs containing OA1 (ref. 16 ). Here we found extensive co-localization of stress-internalized, but not EGFstimulated EGFR with LBPA in serum-starved cells (Fig. 5a) . Consistently, ALIX knockdown in UVC-exposed cells resulted in a similar phenotype to that of Hrs and Tsg101 knockdown, in that UVC-exposed EGFR localized predominantly to the limiting membrane of MVBs containing fewer ILVs and reduced overall EGFR density (Fig 5b,c , quantified in Supplementary Fig. 4a and validated with an alternative siRNA sequence in Supplementary  Fig. 4c ). In contrast, ALIX depletion had no clear effect on MVBs containing EGF-stimulated EGFR. This is the first demonstration that ALIX is required for sorting of stress-internalized EGFR onto ILVs, but, in agreement with previous studies, ALIX is dispensable for sorting of ubiquitinated EGF-bound EGFR onto ILVs 30 .
The perinuclear accumulation of stress-internalized EGFR was remarkably stable and detected Z4 h post UVC exposure ( Supplementary Fig. 3d) ; however, ALIX or Tsg101 knockdown inhibited accumulation of UVC-stimulated EGFR in the perinuclear compartment (Fig. 5d ). This was due to increased EGFR recycling because blockade of clathrin-dependent endocytosis after UVC-induced EGFR internalization (with PITSTOPII) caused the intracellular EGFR pool to return to the plasma membrane in ALIX-and/or Tsg101-depleted, but not control cells. Double Tsg101/ALIX knockdown resulted in accumulation of abnormally large endosomes with stress-internalized EGFR along their limiting membrane (Fig. 5d) , suggesting cooperation between these two factors in stress-internalized EGFR sorting to ILVs. Thus, the intracellular sequestration of stress-internalized EGFR relies on the ESCRT/ALIX-dependent sorting of EGFR onto ILVs of perinuclear MVBs.
Role of stress-induced EGFR traffic in regulating signalling.
What is the functional consequence of the p38-, ESCRT-and ALIX-dependent sequestration of stress-exposed EGFR in this perinuclear subpopulation of MVBs? A previous study has suggested little EGFR activation and increased susceptibility to apoptosis following stress-induced EGFR internalization 6 , whereas others have reported opposing results 31 . We found that stress-induced EGFR internalization, which correlated with p38-specific EGFR-T669 phosphorylation previously shown to be a requisite for internalization 31 , triggered gradual EGFR TK activation, as shown by EGFR-Y1068 phosphorylation (Fig. 6a) .
EGFR TK activity was not required for its internalization, as cells pre-treated with the EGFR inhibitor gefitinib, which prevented UVC-induced EGFR-Y1068 phosphorylation ( Supplementary   Fig. 5a ), still displayed receptor internalization following UVC, but not EGF, exposure ( Supplementary Fig. 5b , quantified in Supplementary Fig. 5c ). The gradual activation of stress-induced EGFR contrasted with the rapid, strong EGFR TK activity triggered by EGF binding, a situation that accounts for the above-mentioned difference in ubiquitination, known to require a threshold of receptor tyrosine phosphorylation 32 . Anisomycininduced p38 activation was sufficient to trigger EGFR internalization and TK activity ( Supplementary Fig. 5d ). Conversely, p38 inhibition abrogated UVC-induced EGFR TK activity (Fig. 6b) . To directly test the role of EGFR internalization in its activation after stress exposure, endocytosis was inhibited by dynamin inhibition (Fig. 6c and Supplementary Fig. 5f ) or AP2a RNA interference (RNAi; Fig. 6d ), as AP2a has previously been shown 33 , and confirmed in the present study ( Supplementary  Fig. 5g ), to be required for UVC/cisplatin-dependent EGFR internalization. Both treatments abolished stress-induced EGFR 
, whereas the latter was abolished by dynasore in UVC-exposed cells (Fig. 6c) . The specificity for EGFR internalization versus other endocytosed cargoes was confirmed in PAE cells expressing EGFR-wt versus EGFR-DAP2, an EGFR mutant for AP2 binding 34 that failed to undergo UVC-induced internalization ( Supplementary Fig. 5h ). We detected increased EGFR activity in EGFR-wt but not -DAP2 cells upon UVC exposure, whereas EGF triggered similar EGFR activation in EGFR-DAP2 and -wt cells (Fig. 6e) . Thus, we show for the first time that although EGF induces EGFR TK activation on the plasma membrane 1 , stress-induced EGFR TK activation/signalling require its internalization.
In parallel with the dual role of p38 in stress-induced EGFR trafficking, p38 activity, present for Z4 h following UVC exposure ( Supplementary Fig. 5e ), was required not only for EGFR activation linked to its internalization, but also for the maintenance of receptor activity post-internalization. Inhibiting p38 activity after UVC-induced EGFR activation and internalization caused EGFR-Y1068 phosphorylation to be lost (Fig. 6f) . Continued EGFR activation does not appear to require direct p38-phosphorylation of EGFR at T669, as this was gradually lost following EGFR internalization (Fig. 6a) . Loss of EGFR-Y1068 phosphorylation by p38 inhibition post-EGFR internalization was not rescued by inhibition of plasma membrane recycling with Rab11 RNAi, indicating that EGFR accumulation in recycling endosomes (Fig. 1d) is not sufficient to maintain EGFR TK activity (Fig. 6f) . Conversely, specific retention of stressinternalized EGFR in MVBs is required to enable EGFR signalling, as knockdown of ALIX, which results in increased levels of EGFR plasma membrane recycling (Fig. 5d) , causes loss of ERK1/2 phosphorylation, and a reduction in EGFR-Y1068 phosphorylation (Fig. 6g) . The residual EGFR-Y1068 phosphorylation detected after ALIX knockdown is presumably due to EGFR being subjected to continuous p38-driven cycles of re-internalization and re-phosphorylation, but prolonged retention in MVBs is required to enable effective downstream signalling.
Although some stress-internalized EGFR is sequestered from the cytosol on ILVs of MVBs, it retains the capacity for Rab11-dependent recycling following p38 inhibition, indicating that mechanisms of back-fusion of EGFR-containing ILVs with MVBlimiting membranes are likely to be in place to allow for downstream signalling from the receptor.
Role of stress-induced EGFR traffic in regulating apoptosis. To determine whether internalization-and intracellular sequestration-dependent signalling from the EGFR modulates cell survival following stress exposure, the effects of manipulating stress-induced EGFR trafficking on entry into apoptosis were assessed by TdT-mediated dUTP nick end labelling (TUNEL) assay. Inhibition of EGFR internalization by AP2a knockdown increased apoptotic cell numbers following UVC or cisplatin treatment ( Fig. 6h and Supplementary Fig. 5i ). The specificity of this effect on EGFR and no other clathrin-dependent cargo was established by measuring the apoptotic response to UVC in EGFR-wt versus À DAP2 PAE cells (Fig. 6h) . Although EGFR endocytosis delayed UVC-induced apoptosis, long-term survival remained poor (9.06 ± 0.01% surviving 24 h after UVC, assessed by MTT assay). Retention of stress-internalized EGFR within MVBs was also required to delay the onset of stress-induced apoptosis, as shown by increased apoptosis of UVC-treated cells following ALIX knockdown (Fig. 6i) . Overall, these results indicate that stress-induced EGFR trafficking and retention into a subset of non-degradative MVBs allows for a fraction of receptors to become activated and signal, resulting in delayed onset of stress-induced apoptosis. Furthermore, MVBs containing stress-induced EGFR might act as a reservoir pool for intact receptor, protecting it from degradation and potentially modulating subsequent signalling upon ligand exposure.
Discussion
This study has led to the elucidation of a novel mechanism of stress-induced EGFR activation linked to its intracellular sequestration in a specific subset of non-degradative MVBs (see Fig. 7 for a schematic diagram). P38-and AP2-dependent EGFR internalization is followed by WASH-dependent segregation into a subset of MVBs that are distinct from those harbouring ligandstimulated EGFR, but related to those that mature into melanosomes in pigmented cells. Although multiple populations of MVBs and ILVs have previously been identified, the mechanisms that regulate sorting between MVBs and their cargo with different destinations remain obscure. This study suggests that WASH-dependent regulation of actin dynamics may play an important role in this sorting.
The subset of MVBs that harbour stress-exposed EGFR has a number of novel features. In contrast to ligand-stimulated EGFR, sorting of EGFR onto the ILVs of these MVBs is independent of ubiquitination, but depends on the ESCRT machinery and ALIX. These ILVs must have the capacity to back-fuse with the MVBlimiting membrane, as they can return to the cell surface upon p38 inhibition. Although back-fusion of ILVs has previously been described 35 , this is the first demonstration that EGFR-containing ILVs can back-fuse. Moreover, although signalling from internalized EGFR has previously been demonstrated, this is the first example to our knowledge where internalization of EGFR and its retention in MVBs is required for the activation and maintenance of activity of the receptor. The intracellular location of the EGFR potentially regulates the availability of EGFR-interacting partners, such as tyrosine phosphatases or the TK Src, known to phosphorylate EGFR increasing its TK activity 36 . ALIX, which sorts EGFR onto ILVs, is also required to maintain EGFR signalling. This at first appears paradoxical because sorting onto ILVs sequesters the catalytic domain of the EGFR from the cytoplasm, and so would be expected to attenuate signalling. However, the demonstration that back-fusion can occur in these MVBs suggests a dynamic cycling between the , ALIX or Tgs101 þ ALIX siRNA-treated HeLa cells were exposed to UVC, incubated for 1 h and fixed, or further treated with PITSTOPII for 1 h. Immunostaining for EGFR (green) shows that depletion of Tsg101 or ALIX inhibits perinuclear EGFR accumulation, whereas EGFR redistributes to the plasma membrane upon PITSTOPII treatment, indicating that Tsg101 and ALIX are required for intracellular retention of EGFR. EGFR is found in very large vacuoles in double Tsg101 þ ALIX knocked-down cells after UVC exposure, before redistribution to the plasma membrane upon PITSTOPII treatment. Scale bars, 10 mm for confocal and 100 nm for EM pictures; 4,6-diamidino-2-phenylindole (DAPI)-stained nuclei, blue.
limiting membrane and ILVs that together maintain the MVB location while also allowing signalling. This possibility is especially appealing given the localization of stress-internalized EGFR to LBPA-containing MVBs, and the previous demonstration of a role for LBPA and ALIX in back-fusion of ILVs within MVBs 30 . Elucidation of the role of ESCRTs/ALIX and p38 in combination in regulating the dynamic behaviour of the stress-exposed EGFR at the level of the MVB is a priority for future studies. Although we primarily used UVC exposure to map EGFR trafficking and signalling, key experiments indicated that exposure to the chemotherapeutic drug cisplatin elicited similar EGFR trafficking and signalling. This has important implications for cancer therapy, as it could explain how chemotherapeutic agents such as cisplatin affect EGFR signalling, contributing to chemotherapy resistance and making tumours refractory to antibody therapies targeting the extracellular domain of EGFR. Further understanding of the molecular regulation of stress-internalized EGFR sorting and its influence on receptor TK activation and downstream signalling will be critical for interpreting its manipulation to increase cancer cell susceptibility to chemotherapy. EGF stimulation triggers plasma membrane receptor activation and ubiquitination before internalization, whereas stress exposure induces p38-dependent EGFR-T669 phosphorylation and internalization into CCPs via interaction with AP2. EGF-bound and stress-internalized EGFR are then sorted from early endosomes onto separate MVB subsets, with stress-internalized EGFR undergoing WASH-dependent co-segregation with pre-melanosomal markers OA1 and fibrillar PMEL, whereas EGF-bound EGFR is retained in degradative MVBs by ubiquitin/ESCRT-dependent sorting onto ILVs and transported to lysosomes for degradation. Stress-exposed EGFR becomes activated post-internalization, and is largely retained in non-degradative MVBs from where it signals by the continued action of p38 in a mechanism that involves ALIX-and ESCRT-dependent receptor sorting onto ILVs, and may include cycles of internalization and back-fusion of ILVs with MVB-limiting membranes. 26 were cultured in Hams F-12 (Lonza) with 10% fetal calf serum. In all experiments, cells were serum-starved overnight (o/n) at 37°C before exposure to 100 J m À 2 UVC with a CL-1000 Ultraviolet Crosslinker (UVP) or treatment with the indicated drugs in serum-free culture medium.
Transient cDNA transfections were performed with Lipofectamine 2000 reagent (Life Technologies) following the manufacturer's guidelines, for 48 h. Human wt EGFR and EGFR-GFP 37 , Rab5-Q79L-DsRed 10 , OA1-myc 16 and PMEL 38 expression vectors have all been described previously.
Transfection with siRNA (purchased from Dharmacon) was performed with Lipofectamine RNAiMAX (Life Technologies), for 72 h. Target sequences for AP2a 33 , Hrs and Tsg101 (ref. 39) have been described previously. Rab11 and ALIX target sequences were the ON-TARGETplus SMART pool (Dharmacon), and as described previously for ALIX RNAi_2 (ref. 40) . Control siRNA was the AllStars-negative control (Qiagen).
See Supplementary Table 1 for details of siRNA sources and sequences.
Reagents and antibodies. Reagents were used at the following concentrations: EGF (100 ng ml À 1 ), SB202190 (10 mM), dynasore (80 mM), bafilomycin (200 nM) and anisomycin (100 mM) were from Sigma-Aldrich; cisplatin (200 mM) was from Mayne Pharma; PITSTOPII (20 mM) was from Abcam; gefitinib (Iressa/ZD1839, 10 mM) was from Astra Zeneca; EGF-AlexaFluor 488 and 647 (200 ng ml À 1 ), Transferrin-AlexaFluor 555 (25 mg ml À 1 ) and LysoTracker Red were from Life Technologies; EGF-horseradish peroxidase (EGF-HRP) (100 ng ml À 1 ) was made from biotinylated EGF and streptavidin-HRP (from Life Technologies). Antibodies for western blotting used were as follows: anti-phospho-EGFR-Y1068, anti-phospho-EGFR-T669, anti-phospho-p38 and anti-phospho-ERK1/2 from Cell Signaling; sheep anti-EGFR from Fitzgerald; anti-AP2a (a gift from M.S. Robinson laboratory); anti-Rab11 from Life Technologies; anti-Hrs from Enzo Lifesciences; anti-Tsg101 from GeneTex; anti-ubiquitin from Santa Cruz; anti-gtubulin (a gift from K. Matter lab) and anti-ALIX from Covalab.
Antibodies for immunofluorescence and cryo-immunoEM used were as follows: anti-EGFR antibody against the extracellular domain of the receptor isolated from the mouse 108 hybridoma (American Type Culture Collection); anti-Lamp1 See Supplementary Table 2 for details of antibody dilutions and catalogue numbers.
Electron microscopy and cryo-immunoelectron microscopy. Colloidal gold sols (British Biocell International) were coupled to anti-EGFR 108 antibody by incubation with antibody at pH 9.3, followed by secondary stabilization with 1% BSA as described 41 . Antibody-gold conjugate was diluted in serum-free media containing 0.2% BSA and incubated with living cells. Conventional EM was performed as previously described 42 . Briefly, cells were cultured on Thermanox coverslips (Agar Scientific), fixed, processed, treated with tannic acid and mounted on Epon stubs. Epon was polymerized overnight at 60°C, and the coverslips removed by heating. 70-nm sections were cut en face and stained with lead citrate before examination. 3,3 0 -Diaminobenzidine (DAB) reaction to reveal EGF-HRP was performed as in ref. 43 by incubation of cells in Tris-buffered saline containing 300-750 mg ml À 1 DAB and 0.02% H 2 O 2 for 30 min at 4°C in the dark.
Cells were prepared for cryo-immunoEM by fixing with 4% paraformaldehyde þ 0.1% glutaraldehyde in 0.1 M phosphate buffer at pH 7.4 and pelleting in 12% gelatin. Subsequently, after infusion with 2.3 M sucrose, 80 nm sections were cut at À 120°C and collected in 2.3 M sucrose/2% methylcellulose (1:1 ratio). Sections were immuno-labelled as in ref. 41 by incubating with primary antibody and gold-tagged donkey anti-goat (Aurion) or gold-tagged protein A (UMC Utrecht).
Samples were viewed on a JEOL 1010 TEM, and images were acquired in a Gatan OriusSC100B charge-coupled device camera, and gold particles quantified in at least five cells per experiment using ImageJ.
Immunofluorescence. Cells were fixed with 4% paraformaldehyde in PBS for 20 min, permeabilized in 0.5% Triton X-100 for 10 min and blocked with 5% BSA for 1 h. After labelling with primary antibodies o/n at 4°C, cells were washed in PBS and incubated with Alexa Fluor-conjugated secondary antibodies for 45 min at room temperature. All antibody incubations were in 1% BSA in PBS.
For UVC þ EGF sequential endocytosis experiments, HeLa cells were UVCexposed and incubated for 1 h in the presence of excess anti-EGFR 108 antibody, followed by stimulation with EGF-AlexaFluor 488 for 30 min (or with EGFAlexaFluor 647 for 3 h in Rab5-Q79L-DsRed-transfected cells), fixed and processed for immunofluorescence with AlexaFluor 555 secondary antibody to label EGFR. Note that 108 antibody labels all receptors present at the plasma membrane and does not significantly dissociate from EGFR following initial binding so that both non-EGF-and EGF-bound EGFR will be positive for 108.
Coverslips were mounted in Prolong Gold antifade reagent with 4,6-diamidino-2-phenylindole (Life Technologies) and images were acquired with a Leica DM-IRE2 microscope and TCS SP2 AOBS confocal system with a 63 Â /1.4 numerical aperture oil-immersion objective (Leica). Quantification of co-localization was performed by measurement of Mander's coefficient in at least 20 cells per experiment using ImageJ.
Immunoprecipitation and western blotting. EGFR was immunoprecipitated with 108 EGFR antibody bound to protein G Sepharose Fast Flow beads (Sigma). Immunoprecipitates were extensively washed and analysed by western blotting.
For western blotting, cells were lysed in lysis buffer [20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% NP40 (or Triton-X100), pH 7.4 plus protease inhibitor cocktail (Calbiochem set I) and phosphatase inhibitor cocktail (Calbiochem set II)]; lysates were fractioned by SDS-PAGE on 10% gels under reducing conditions and immunoblotted onto nitrocellulose membranes. Bands were detected by using enhanced chemiluminescence (Pierce) and exposed films developed on a SRX-101A Film Processor (Konica).
See Supplementary Figure 6 for uncropped scans of blots.
Surface downregulation assay. Approximately 65,000 cells were seeded in six replicates per condition in a 48-well plate. Cells were serum starved o/n and following the appropriate treatment, fixed in 4% paraformaldehyde in PBS for 20 min. Half of the wells were permeabilized in 0.1% Triton X-100 for 8 min to quantify total EGFR level while the other half were left untreated to quantify surface level of EGFR. Cells were processed for in-cell western with 108 anti-EGFR antibody followed by IRDye 800CW donkey anti-mouse IgG secondary antibody (LI-COR) and DRAQ5 (to quantify cell number). Images were taken at 700 and 800 nm with a LI-COR Odyssey Infrared Imaging System and processed in ImageJ. Integrated density for the same area was quantified for each well and normalized by cell number.
Neutral red assay. Approximately 20,000 cells were seeded in replicates of eight for each condition in a 96-well plate. Cells were serum-starved o/n and, following the appropriate treatment, incubated in 0.005% neutral red solution (Sigma) for 2.5 h to allow for crystal formation. The reaction was stopped in 50% ethanol þ 1% glacial acetic acid solution to dissolve the crystals. The content of each well was resuspended, briefly spun and placed in a new 96-well plate. The absorbance at 550 nm was measured using a plate reader.
TUNEL assay. Cells were fixed, permeabilized in 0.1% Triton X-100 for 5 min and processed using the In Situ Cell Death Detection Kit, TMR red (Roche) following the manufacturer's instructions. Five to ten images were taken in random areas and a minimum of 200 cells were counted in two replicates per experiment.
MTT assay. Approximately 65,000 cells were seeded in replicates of eight for each condition in a 48-well plate. Cells were serum-starved o/n and, following the appropriate treatment, incubated in DMEM þ 0.5 mg ml À 1 MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Sigma) for 3 h to allow for crystal formation. Medium was removed and cells were incubated for 10 min in dimethylsulphoxide to dissolve the crystals, and absorbance at 570 nm was measured using a plate reader.
